| Chronic myeloid leukemia stem cells M Houshmand, G Simonetti, P Circosta, V Gaidano, A Cignetti, ... Leukemia 33 (7), 1543-1556, 2019 | 192 | 2019 |
| Nanocarriers as Magic Bullets in the Treatment of Leukemia M Houshmand, F Garello, P Circosta, R Stefania, S Aime, G Saglio, ... Nanomaterials 10 (2), 276, 2020 | 52 | 2020 |
| Mimicking the acute myeloid leukemia niche for molecular study and drug screening M Houshmand, M Soleimani, A Atashi, G Saglio, M Abdollahi, ... Tissue Engineering Part C: Methods 23 (2), 72-85, 2017 | 49 | 2017 |
| Bone marrow microenvironment: The guardian of leukemia stem cells M Houshmand, TM Blanco, P Circosta, N Yazdi, A Kazemi, G Saglio, ... World journal of stem cells 11 (8), 476, 2019 | 48 | 2019 |
| Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome M Houshmand, F Garello, R Stefania, V Gaidano, A Cignetti, M Spinelli, ... Cancers 13 (6), 1311, 2021 | 31 | 2021 |
| Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia N YAZDI, M HOUSHMAND, A ATASHI, A KAZEMI, ALIA NAJMEDINI, ... Turkish Journal of Biology 42 (5), 405-413, 2018 | 30 | 2018 |
| The Synergism Between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia V Gaidano, M Houshmand, N Vitale, G Carrà, A Morotti, V Tenace, ... Cancers 13 (5), 1003, 2021 | 28 | 2021 |
| Long non-coding RNA PVT1 as a novel candidate for targeted therapy in hematologic malignancies M Houshmand, N Yazdi, A Kazemi, A Atashi, AA Hamidieh, AA Najemdini, ... The international journal of biochemistry & cell biology 98, 54-64, 2018 | 27 | 2018 |
| Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold … S Sainas, M Giorgis, P Circosta, V Gaidano, D Bonanni, AC Pippione, ... Journal of medicinal chemistry 64 (9), 5404-5428, 2021 | 25 | 2021 |
| Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells M Houshmand, A Kazemi, A Anjam Najmedini, MS Ali, V Gaidano, ... Journal of Clinical Medicine 10 (24), 5805, 2021 | 12 | 2021 |
| MicroRNA microarray profiling during megakaryocyte differentiation of cord blood CD133+ hematopoietic stem cells M Houshmand, MN Hagh, M Soleimani, AA Hamidieh, S Abroun, MN Zarif Cell Journal (Yakhteh) 20 (2), 195, 2018 | 7 | 2018 |
| Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia M Houshmand, N Vitale, F Orso, A Cignetti, I Molineris, V Gaidano, ... Cell Death & Disease 13 (6), 1-13, 2022 | 6 | 2022 |
| The anticancer effects of pharmacological inhibition of autophagy in acute erythroid leukemia cells A Kazemi, M Sadri, M Houshmand, N Yazdi, MN Zarif, A Anjam-Najmedini, ... Anti-cancer drugs 29 (10), 944-955, 2018 | 6 | 2018 |
| Immature CML cells implement a BMP autocrine loop to escape TKI treatment M Houshmand, P Circosta, G Saglio Transl Cancer Res 7, S722-S5, 2018 | 3 | 2018 |
| The TEMPI Syndrome: A Monoclonal Gammopathy of Clinical Significance Driving Erythropoietin Production DB Sykes, MA Houshmand, TP Charles, J Wrammert, WA Schroyens Blood 144, 3293, 2024 | | 2024 |
| POSTER: MM-340 A Novel Signaling Pathway Involved in Erythropoietin Production A Houshmand, S Mei, TP Charles, J Wrammert, DB Sykes Clinical Lymphoma Myeloma and Leukemia 23, S218, 2023 | | 2023 |
| MM-340 A Novel Signaling Pathway Involved in Erythropoietin Production A Houshmand, S Mei, TP Charles, J Wrammert, DB Sykes Clinical Lymphoma Myeloma and Leukemia 23, S490-S491, 2023 | | 2023 |
| CML-164 Dihydroorotate Dehydrogenase Inhibition Reveals Metabolic Vulnerability in Chronic Myeloid Leukemia M Houshmand, N Vitale, F Orso, A Cignetti, I Molineris, V Gaidano, ... Clinical Lymphoma Myeloma and Leukemia 22, S288-S289, 2022 | | 2022 |
| A new pro-apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor S Sainas, P Circosta, N Villella, E Martino, AC Pippione, M Houshmand, ... EFMC-YMCS 2021 8th EFMC Young Medicinal Chemists’ Symposium, 154-154, 2021 | | 2021 |
| A differentiating and apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor S Sainas, P Circosta, M Giorgis, AC Pippione, M Marraudino, ... EFMC-ISMC 2021, XXVI EFMC International Symposium on Medicinal Chemistry …, 2021 | | 2021 |
Giuseppe SaglioProfessore di Ematologia, Universita' di TorinoBestätigte E-Mail-Adresse bei unito.it